Loading…Loading…
At the Benzinga Cannabis Capital Conference in Florida, Cresco Labs’ CRLBF CEO Charlie Bachtell shared optimistic views on cannabis rescheduling, emphasizing the importance of the process it’s undergoing.
“This is going through the process it needs to… it’s a matter of when,” Bachtell highlighted, underscoring the significance of Health and Human Services’ acknowledgment of cannabis’ medicinal value—a monumental step for the industry.
The Political Landscape And SAFER Banking
With a presidential election on the horizon, Bachtell discussed the political implications of rescheduling cannabis. He noted the unlikelihood of a new administration reversing progress, given the industry’s substantial economic footprint and the growing public support for cannabis reform.
Loading…Loading…
Additionally, Bachtell touched on the SAFER Banking Act, pointing out the critical support from influential senators and its potential to further legitimate the cannabis industry through legislative action.
Beyond Rescheduling: A Vision For The Future
Bachtell envisioned a domino effect following rescheduling, leading to broader legislative reforms and regulatory clarity.
He said that rescheduling would be just the beginning and would pave
the way for more comprehensive changes that could significantly impact the industry.
“When that first domino falls, it opens the door to every domino after that also falling,” he said, suggesting a cascade of positive developments for cannabis policy in the United
